Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial. (linkinghub.elsevier.com)

Authors: Chalabi M … Haanen JBAG Journal: The Lancet Published: 2026-10-21 DOI: https://doi.org/10.1016/S0140-6736(26)01602-8